CBT-1 with Doxorubicin

General Clinical Trials and Research Updates
1

A new trial, not yet open to recruitment will test the combination of CBT-1, a drug developed to reverse multi-drug resistance, and Doxorubicin:


More about CBT-1:
http://cbapharma.com/CBT1/cbt1.html